Increased liver enzymes in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

Endocrine Journal

Volumn 56, Issue 4, 2009, Pages 601-608

  Falhammar, Henrik ^a,b   Filipsson, Helena ^c   Holmdahl, Gundela ^c   Janson, Per Olof ^c   Nordenskjöld, Agneta ^a,b   Hagenfeldt, Kerstin ^b   Thorén, Marja ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Congenital adrenal hyperplasia; Glucocorticoids; Liver function tests; Non alcoholic fatty liver disease

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CORTISONE ACETATE; DEXAMETHASONE; FLUDROCORTISONE; GAMMA GLUTAMYLTRANSFERASE; HYDROCORTISONE; INSULIN; PREDNISOLONE; STEROID 21 MONOOXYGENASE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY FAT; CONGENITAL ADRENAL HYPERPLASIA; CONTROLLED STUDY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENOTYPE; GLUCOSE METABOLISM; GROUPS BY AGE; HUMAN; INSULIN BLOOD LEVEL; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; NONALCOHOLIC FATTY LIVER; OBESITY; PHENOTYPE; STEROID 21 MONOOXYGENASE DEFICIENCY; WAIST CIRCUMFERENCE;

ADOLESCENT; ADRENAL HYPERPLASIA, CONGENITAL; ADULT; ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASES; BLOOD GLUCOSE; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; INSULIN; LIVER; LIVER FUNCTION TESTS; MIDDLE AGED; STEROID 21-HYDROXYLASE; WAIST CIRCUMFERENCE;

EID: 68449085272     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K08E-312     Document Type: Article

References (30)

1. White PC, Speiser PW (2000) Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 21: 245-291. (Pubitemid 32275589)
2. Falhammar H, Filipsson H, Holmdahl G, Janson PO, Nordenskjöld A, Hagenfeldt K, Thorén M (2007) Metabolic profile and body composition in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 92: 110-116. (Pubitemid 46067517)
3. Falhammar H, Thorén M, Hagenfeldt K (2008) A 31-year-old woman with infertility and polycystic ovaries was diagnosed with non-classic congenital adrenal hyperplasia due to a novel CYP21 mutation. J Endocrinol Invest 31: 176-180. (Pubitemid 351596980)
4. Schwimmer JB, Khorram O, Chiu V, Schwimmer WB (2005) Abnormal aminotransferase activity in women with polycystic ovary syndrome. Fertil Steril 83: 494-497. (Pubitemid 40221817)
5. Setji TL, Holland ND, Sanders LL, Pereira KC, Diehl AM, Brown AJ (2006) Nonalcoholic steatohepatitis and nonalcoholic fatty liver disease in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 91: 1741-1747.
6. Adams LA, Lindor KD (2007) Nonalocoholic fatty liver disease. Ann Epidemiol 17: 863-869.
7. Falhammar H, Filipsson H, Holmdahl G, Janson PO, Nordenskjöld A, Hagenfeldt K, Thorén M (2007) Fractures and bone mineral density in adult women with 21-hydroxylase deficiency. J Clin Endocrinol Metab 92: 4643-4649. (Pubitemid 350223439)
8. Nordenskjöld A, Holmdahl G, Frisén L, Falhammar H, Filipsson H, Thorén M, Janson PO, Hagenfeldt K (2008) Type of Mutation and Surgical Procedure Affect Long-term Quality of life for Women with Congenital Adrenal Hyperplasia. J Clin Endocrinol Metab 93: 380-386. (Pubitemid 351240807)
9. Hagenfeldt K, Janson PO, Holmdahl G, Falhammar H, Filipsson H, Frisén L, Thorén M, Nordenskjöld A (2008) Fertility and pregnancy outcome in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hum Reprod 23: 1607-1613. (Pubitemid 351809706)
10. Lajic S, Clauin S, Robins T, Vexiau P, Blanche H, Bellanne-Chantelot C, Wedell A (2002) Novel mutations in CYP21 detected in individuals with hyperandrogenism. J Clin Endocrinol Metab 87: 2824-2829. (Pubitemid 34655350)
11. Aronne LJ (2002) Classification of obesity and assessment of obesity-related health risks. Obes Res 10 suppl 2: 105s-115s.
12. Prati D, Taioli E, Zanella A, Torre ED, Butelli S, Del Vecchio E, Vianello L, Zanuso F, Mozzi F, Milani S, Conte D, Colombo M, Sirchia G (2002) Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 137: 1-9. (Pubitemid 34705370)
13. Friedewald WT, Levy RL, Fredrickson DS (1972) Estimation of concentration of low density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge. Clin Chem 18: 499-502.
14. Bang P, Eriksson U, Sara V, Wivall IL, Hall K (1991) Comparison of acid ethanol extraction and acid gel filtration prior to IGF-I and IGF-II radioimmunoassays: improvement of determination in acid ethanol extracts by the use of truncated IGF-1 as radioligand. Acta Endocrinol (Copenh) 124: 620-629.
15. Hilding A, Hall K, Wivall-Helleryd IL, Sääf M, Melin AL, Thorén M (1999) Serum levels of insulin-like growth factor 1 in 152 patients with growth hormone deficiency, aged 19-82 years, in relation to those in healthy subjects. J Clin Endocrinol Metab 84: 2013-2019. (Pubitemid 30647027)
16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostatis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419. (Pubitemid 15018832)
17. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Targher G, Alberiche M, Bonadonna RC, Muggeo M (1998) Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes 47: 1643-1649. (Pubitemid 28445355)
18. Mazess RB, Barden HS, Bisek JP, Hansson J (1990) Dual energy x-ray absorptiometry for total body and regional bone mineral and soft tissue composition. Am J Clin Nutr 51: 156-163.
19. Liddle GW (1961) Clinical pharmacology of anti-inflammatory steroids. Clin Pharmacol Ther 2: 615-635.
20. Miller WL (1991) The adrenal cortex. in: Rudolph AM, Hoffman JIE (eds) Pediatrics. Appleton & Lange, Norwalk: 1584-1613.
21. Kariv R, Leshno M, Beth-Or A, Strul H, Blendis L, Kokia E, Noff D, Zelber-Sagie S, Sheinberg B, Oren R, Halpern Z (2006) Re-evaluation of serum alanine aminotransferase upper normal limit and its modulating factors in a large-scale population study. Liver Int 26: 445-450.
22. Piton A, Poynard T, Imbert-Bismut F, Khalil L, Delattre J, Pelissier E, Sansonetti N, Opolon P (1998) Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. MULTIVIRC Group. Hepatology 27: 1213-1219. (Pubitemid 28227846)
23. Hoffmann G, Berglund G, Elmståhl S, Eriksson S, Verbaan H, Widell A, Lindgren S (2000) Prevalence and clinical spectrum of chronic viral hepatitis in a middle-aged swedish general urban population. Scand J Gastroenterol 35: 861-865. (Pubitemid 30687879)
24. Lonardo A, Trande P (2000) Are there any sex differences in fatty liver? A study of glucose metabolism and body fat distribution. J Gastroenterol Hepatol 15: 775-782. (Pubitemid 30615062)
25. Rockall AG, Sohaib SA, Evans D, Kaltsas G, Isidori AM, Monson JP, Besser GM, Grossman AB, Reznek RH (2003) Hepatic steatosis in Cushing's syndrome: a radiological assessment using computed tomography. Eur J Endocrinol 149: 543-548. (Pubitemid 38054698)
26. ITOH S, IGARASHI M, TSUKADA Y, ICHINOE A (1977) Nonalcoholic fatty liver with alcoholic hyalin after long term glucocorticoid therapy. Acta Hepatogastroenterol 24: 415-418.
27. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH (2004) Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40: 1387-1395. (Pubitemid 39657013)
28. Scharf JG, Schmitz F, Frystyk J, Skjaerbeck C, Moesus H, Blum W F, Ramadori G, Hartmann H (1996) Insulin-like growth factor-I serum concentrations and patterns of insulin-like binding proteins in patients with chronic liver disease. J Hepatol 25: 689-699. (Pubitemid 26373887)
29. Miller KK, Biller BMK, Lipman JG, Bradwin G, Rifai N, Klibanski A (2005) Truncal adiposity, relative growth hormone deficiency and cardiovascular risk. J Clin Endocrinol Metab 90: 768-774. (Pubitemid 40279194)
30. Rochling FA (2001) Evaluation of abnormal liver tests. Clin Cornerstone 3: 1-12.